Trials / NCT01024803
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Completed N/A Gene therapy, Retinal implant
- Sponsor
- Retina Implant AG
- Treatment
- Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa, Retinal Degeneration
- Ages
- 18 Years to 78 Years
- Enrollment
- 39 participants
- Started
- 2009-12
- Main results expected
- 2017-04
- Results posted
- Not yet
- Record last updated
- 2018-09-05
What the study is testing
Patients suffering from hereditary retinal degeneration receive a retinal implant to restore sight.
Subretinal implant "ON" results in significant visual acuity improvement, when compared to "OFF" condition.
Where it runs
Germany (3)
- Helmut Sachs, MD, PD, Dresden
- Johann Roider, MD, Prof., Kiel
- Karl-Ulrich Bartz-Schmidt, MD, Prof., Tübingen
Hungary (1)
- Miklos Resch, MD, PhD, Budapest
United Kingdom (2)
- Timothy L Jackson, MB.ChB, PhD, FRCOphth, London
- Robert MacLaren, MD, Prof., DPhil DipEd FRCOphth FRCS, Oxford